The EFSUMB guidelines and recommendations for the clinical practice of contrast-enhanced ultrasound (CEUS) in non-hepatic applications: update 2017 (long …

PS Sidhu, V Cantisani, CF Dietrich… - Ultraschall in der …, 2018 - thieme-connect.com
Thieme E-Journals - Ultraschall in der Medizin - European Journal of Ultrasound / Full Text DE
EN Home Products Journals Books Book Series Service Library Service Help Contact Portal …

Focal therapy in primary localised prostate cancer: the European Association of Urology position in 2018

HG van der Poel, RCN van den Bergh, E Briers… - European urology, 2018 - Elsevier
Radical treatment of localised prostate cancer is recognised to be an unnecessary
intervention or overtreatment in many men. Consequently, there has been a rapid uptake in …

Liquid biopsy potential biomarkers in prostate cancer

J Neuhaus, B Yang - Diagnostics, 2018 - mdpi.com
Prostate cancer (PCa) is the second most common cancer in men worldwide with an
incidence of 14.8% and a mortality of 6.6%. Shortcomings in comprehensive medical check …

A 12-year follow-up of ANNA/C-TRUS image-targeted biopsies in patients suspicious for prostate cancer

T Tokas, B Grabski, U Paul, L Bäurle, T Loch - World journal of urology, 2018 - Springer
Purpose PSA screening has been rehabilitated. PSA is not specific and can be elevated by
benign reasons. Additionally, a subgroup of patients with prostate hyperplasia may harbor …

[HTML][HTML] Head-to-head comparison of prostate cancer risk calculators predicting biopsy outcome

N Pereira-Azevedo, JFM Verbeek… - Translational …, 2018 - ncbi.nlm.nih.gov
Background Multivariable risk calculators (RCs) predicting prostate cancer (PCa) aim to
reduce unnecessary workup (eg, MRI and biopsy) by selectively identifying those men at risk …

Die EFSUMB-Leitlinien und Empfehlungen für den klinischen Einsatz des kontrastverstärkten Ultraschalls (CEUS) bei nicht-hepatischen Anwendungen: Update 2017 …

PS Sidhu, V Cantisani, CF Dietrich, OH Gilja… - Ultraschall in der …, 2018 - research.tue.nl
Die EFSUMB-Leitlinien und Empfehlungen für den klinischen Einsatz des kontrastverstärkten
Ultraschalls (CEUS) bei nicht- hepat Page 1 Die EFSUMB-Leitlinien und Empfehlungen für den …

MRI-TRUS fusion biopsy of the prostate: Quality of image fusion in a clinical setting

B Schlenker, M Apfelbeck, A Buchner… - Clinical …, 2018 - content.iospress.com
MATERIALS AND METHODS: Single arm study including patients with elevated prostate
specific antigen (PSA) and a multiparametric MRI showing a suspicious lesion underwent a …

Diagnosis in Prostate Cancer/Prostat Kanserinde Tani

F Yencilek, O Koca, M Kuru - Nuclear Medicine Seminars, 2018 - go.gale.com
Prostate cancer is a disease with increasing incidence that can be fully cured thanks to the
innovations in diagnosis and treatment when detected in local stage. It is the second most …

[PDF][PDF] DIAGNOSTIKA KARCINOMU PROSTATY POMOCÍ FÚZNÍ BIOPSIE.

J Stejskal, V Jašková, A Pavličko, J Votrubová… - Czech Urology/Ceska …, 2018 - czechurol.cz
DIAGNOSTIKA KARCINOMU PROSTATY POMOCÍ FÚZNÍ BIOPSIE Page 1 87 Ces Urol 2018;
22(2): 87–98 PŘEHLEDOVÝ ČLÁNEK DIAGNOSTIKA KARCINOMU PROSTATY POMOCÍ FÚZNÍ …

Diagnosis in Prostate Cancer

F Yencilek, O Koca, M Kuru - Nukleer Tıp Seminerleri, 2018 - search.proquest.com
Prostat kanseri günümüzde sıklığı giderek artan, tanı ve tedavisindeki yeniliklerle birlikte
lokalize olarak yakalandığında tam olarak kür sağlanabilecek bir hastalıktır. Prostat kanseri …